Influential Factors to Prolonged Tuberculosis Treatment Duration and Multidrug-resistant Tuberculosis Incidence
Journal of Health Informatics and Statistics. 2016;41(3):344-350 
Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia
BMC Public Health. 2018;18(1):
Multidrug-Resistant Tuberculosis Treatment as Prevention: Modeling the Population-Level Impact of Expanded Treatment for Multidrug-Resistant Tuberculosis
Open Forum Infectious Diseases. 2015;2(suppl_1):
Presumptive treatment of multidrug-resistant tuberculosis in household contacts
Indian Journal of Tuberculosis. 2016;63(1):64
Determinants Of Multidrug Resistant Tuberculosis Among Adultsundergoing Treatment For Tuberculosis In Tigray Region, Ethiopia: A Case Control Study
. 2020;
Drug-induced hypothyroidism during anti-tuberculosis treatment of multidrug-resistant tuberculosis: Notes from the field
Indian Journal of Tuberculosis. 2016;63(4):277
Recent advancement and future perspective for the treatment of multidrug-resistant tuberculosis
Nanotechnology Based Approaches for Tuberculosis Treatment. 2020;231-250
Contributing risk factors towards the prevalence of multidrug-resistant tuberculosis in Malaysia: A systematic review
Tuberculosis. 2020;122:101925
Pattern of prevalence, risk factors and treatment outcomes among Egyptian patients with multidrug resistant tuberculosis
Egyptian Journal of Chest Diseases and Tuberculosis. 2017;66(3):405-411
Predictors of Treatment Outcomes among Multidrug Resistant Tuberculosis Patients in Tanzania
Tuberculosis Research and Treatment. 2019;2019:1-10